Blog

Here is the list.

From MedicalExpress: “Salk Institute researchers have found that an experimental drug candidate aimed at combating Alzheimer’s disease has a host of unexpected anti-aging effects in animals.The Salk team expanded upon their previous development of a drug candidate, called J147, which

From New Scientist: “One-year-old Layla was dying from leukaemia after all conventional treatments failed. “We didn’t want to give up on our daughter, though, so we asked the doctors to try anything,” her mother Lisa said in a statement released

From ScienceMag.org: “Harvard stem cell biologist Amy Wagers, cardiologist Richard Lee of the Harvard-affiliated Brigham and Women’s Hospital in Boston, and their colleagues claim that a specific protein, GDF11, may explain young blood’s beneficial effects. They have reported that blood

A national team of researchers has developed a first-of-its-kind, 3D-printed guide that helps regrow both the sensory and motor functions of complex nerves after injury. The groundbreaking research has the potential to help more than 200,000 people annually who experience

This is rather exciting news. If it works in humans, it would be a game changer. A number of media sites wrote about this work by Dr Panos Anastasiadis and his team at the Mayo Clinic. Here’s the BBC’s story.

Here’s an informative article by David Ewing Duncan on gut bacteria and the brain.

According to Nature, researchers are poised to meet with the FDA this month to discuss “medicines that delay ageing-related disease as legitimate drugs.” This makes sense, given that there are a number of scientific teams working on such compounds. Nir

A huge advance. Here’s the story from Discover Mag: “A team of regenerative scientists and surgeons at Massachusetts General Hospital successfully grew a semi-functional rat forelimb in the lab, employing a technique previously used to build bio-artificial organs. If someday

From the WSJ: “A Food and Drug Administration advisory panel has recommended the first drug to help combat female sexual dysfunction. And Sprout Pharmaceuticals, which owns the pill, hopes agency approval will occur in mid-August.”